Efficacy of raltegravir-containing regimens in antiretroviral-naïve and -experienced individuals in routine clinical practice

This study shows again the overall long-term efficacy of raltegravir-based ART and furthermore gives reference for a comparable efficacy of dual and standard nucleos(t)ide reverse transcriptase inhibitor–backbone regimens in experienced patients on raltegravir over a period of 48 weeks in a real-life cohort where patients with severe comorbidities were included.

Source: International Journal of STD and AIDS - October 27, 2016 Category: Global & Universal Authors: Jaeckle, M., Khaykin, P., Haberl, A., De Leuw, P., Schüttfort, G., Stephan, C., Wolf, T. Tags: Original research articles Source Type: research